Myrtenal
Appearance
Names | |
---|---|
IUPAC name
6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde
| |
Other names
(1R)-2-Pinen-10-a
Benihinal | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.008.432 |
EC Number |
|
MeSH | myrtenal |
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C10H14O | |
Molar mass | 150.221 g·mol−1 |
Appearance | Colorless liquid |
Density | 0.987 g/cm3 |
Boiling point | 220-221 °C |
Hazards | |
GHS labelling: | |
Warning | |
H227 | |
P210, P280, P370+P378, P403+P235, P501 | |
Flash point | 78 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Myrtenal is a bicyclic monoterpenoid with the chemical formula C10H14O. It is a naturally occurring molecule that can be found in numerous plant species including Hyssopus officinalis, Salvia absconditiflora, and Cyperus articulatus.[1]
Biological research
Myrtenal was shown to inhibit acetylcholinesterase, which is a common method of treatment of alzheimer's disease and dementia, in-vitro.[2] In addition, mytenal has been shown to have antioxidant properties in rats.[3]
See also
References
- ^ "LOTUS: Natural Products Online". lotus.naturalproducts.net. Retrieved 2022-08-17.
{{cite web}}
: CS1 maint: url-status (link) - ^ Kaufmann D, Dogra AK, Wink M (October 2011). "Myrtenal inhibits acetylcholinesterase, a known Alzheimer target". The Journal of Pharmacy and Pharmacology. 63 (10): 1368–1371. doi:10.1111/j.2042-7158.2011.01344.x. PMID 21899553. S2CID 44962827.
- ^ Lokeshkumar B, Sathishkumar V, Nandakumar N, Rengarajan T, Madankumar A, Balasubramanian MP (September 2015). "Anti-Oxidative Effect of Myrtenal in Prevention and Treatment of Colon Cancer Induced by 1, 2-Dimethyl Hydrazine (DMH) in Experimental Animals". Biomolecules & Therapeutics. 23 (5): 471–478. doi:10.4062/biomolther.2015.039. PMC 4556208. PMID 26336588.